Literature DB >> 23786292

Alternative xeno-free biomaterials derived from human umbilical cord for the self-renewal ex-vivo expansion of mesenchymal stem cells.

Sun-Mi Kim1, Sung-Hwan Moon, Youngjun Lee, Gi Jin Kim, Hyung-Min Chung, Yong-Soo Choi.   

Abstract

Mesenchymal stem cells (MSCs) are attractive candidates for novel cell-therapy applications. However, the in vitro expansion of MSCs typically depends on the presence of fetal bovine serum (FBS) and coating materials derived from animal sources, which may cause contamination in clinical applications. In this study, we investigated whether human umbilical cord extract (UCE) could serve as a serum replacement and whether collagen purified from umbilical cord (UC-collagen) could act as an extracellular matrix (ECM) for the in vitro culture of MSCs derived from human UC (UC-MSCs). A total of 5.61 ± 0.54 mg UCE and 18.41 ± 2.42 mg collagen were extracted, and 1.3 ± 0.2 × 10⁵ cells were isolated from 1 g of UC, as determined by the expression of typical MSC surface markers. Importantly, the proliferation and stemness of the UC-MSCs cultured with the UCE media were similar to those cultured under FBS conditions on UC-collagen-treated plates for eight passages. Based on these results, we suggest that UCs, which are discarded as medical waste, represent a viable alternative source of xeno-free biomaterials to replace animal-derived serum and ECM materials for the cultivation of various cell types, including UC-MSCs, adipose tissue-derived MSCs, bone marrow-derived MSCs, and fibroblasts. This innovative xeno-free MSCs culture system can overcome many of the problems associated with immunogenicity, and it will further contribute to the enhancement of treatment efficiency.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23786292     DOI: 10.1089/scd.2013.0067

Source DB:  PubMed          Journal:  Stem Cells Dev        ISSN: 1547-3287            Impact factor:   3.272


  13 in total

1.  Novel in vitro culture condition improves the stemness of human dermal stem/progenitor cells.

Authors:  Joong Hyun Shim; Tae Ryong Lee; Dong Wook Shin
Journal:  Mol Cells       Date:  2013-11-14       Impact factor: 5.034

2.  Umbilical cord mesenchymal stem cell-conditioned media prevent muscle atrophy by suppressing muscle atrophy-related proteins and ROS generation.

Authors:  Chan-Mi Park; Mi Jin Kim; Sun-Mi Kim; Jin-Ho Park; Z-Hun Kim; Yong-Soo Choi
Journal:  In Vitro Cell Dev Biol Anim       Date:  2015-09-15       Impact factor: 2.416

3.  Mitochondrial Transplantation Modulates Inflammation and Apoptosis, Alleviating Tendinopathy Both In Vivo and In Vitro.

Authors:  Ji Min Lee; Jung Wook Hwang; Mi Jin Kim; Sang Youn Jung; Kyung-Soo Kim; Eun Hee Ahn; Kyunghoon Min; Yong-Soo Choi
Journal:  Antioxidants (Basel)       Date:  2021-04-28

4.  Autoserum: An Optimal Supplement for Bone Marrow Mesenchymal Stem Cells of Liver-Injured Rats.

Authors:  Qinglin Zhang; Xun Sun; Jianxun Ding; Ping He; Yujia Liu; Hongjing Cheng; Changlin Zhou; Xiangwei Meng
Journal:  Stem Cells Int       Date:  2015-05-24       Impact factor: 5.443

5.  Attenuation of Postischemic Genomic Alteration by Mesenchymal Stem Cells: a Microarray Study.

Authors:  Chunggab Choi; Seung-Hun Oh; Jeong-Eun Noh; Yong-Woo Jeong; Soonhag Kim; Jung Jae Ko; Ok-Joon Kim; Jihwan Song
Journal:  Mol Cells       Date:  2016-02-29       Impact factor: 5.034

Review 6.  Adipose-derived stem cells: selecting for translational success.

Authors:  Kavan S Johal; Vivien C Lees; Adam J Reid
Journal:  Regen Med       Date:  2015       Impact factor: 3.806

7.  Umbilical cord extracts improve diabetic abnormalities in bone marrow-derived mesenchymal stem cells and increase their therapeutic effects on diabetic nephropathy.

Authors:  Kanna Nagaishi; Yuka Mizue; Takako Chikenji; Miho Otani; Masako Nakano; Yusaku Saijo; Hikaru Tsuchida; Shinichi Ishioka; Akira Nishikawa; Tsuyoshi Saito; Mineko Fujimiya
Journal:  Sci Rep       Date:  2017-08-16       Impact factor: 4.379

8.  Delivery of exogenous mitochondria via centrifugation enhances cellular metabolic function.

Authors:  Mi Jin Kim; Jung Wook Hwang; Chang-Koo Yun; Youngjun Lee; Yong-Soo Choi
Journal:  Sci Rep       Date:  2018-02-20       Impact factor: 4.379

Review 9.  Culturing human intestinal stem cells for regenerative applications in the treatment of inflammatory bowel disease.

Authors:  Fredrik Eo Holmberg; Jakob B Seidelin; Xiaolei Yin; Benjamin E Mead; Zhixiang Tong; Yuan Li; Jeffrey M Karp; Ole H Nielsen
Journal:  EMBO Mol Med       Date:  2017-05       Impact factor: 12.137

10.  CD73, CD90, CD105 and Cadherin-11 RT-PCR Screening for Mesenchymal Stem Cells from Cryopreserved Human Cord Tissue.

Authors:  Hung Pham; Richard Tonai; Miya Wu; Chiara Birtolo; Monica Chen
Journal:  Int J Stem Cells       Date:  2018-05-30       Impact factor: 2.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.